Loading...
•
Dec 31, 2020
Thermo Fisher Q4 2020 Earnings Report
Thermo Fisher Scientific reported strong growth in revenue, earnings, and free cash flow, driven by the societal response to the pandemic and momentum in the base business.
Key Takeaways
Thermo Fisher Scientific Inc. reported a significant increase in its financial performance for the fourth quarter and full year ended December 31, 2020. The company's fourth-quarter revenue grew by 54% to $10.55 billion, with GAAP diluted EPS increasing by 151% to $6.24 and adjusted EPS increasing by 100% to $7.09.
Fourth quarter revenue grew 54% to $10.55 billion.
Fourth quarter GAAP diluted earnings per share (EPS) increased 151% to $6.24.
Fourth quarter adjusted EPS increased 100% to $7.09.
Generated $3.2 billion of COVID-19 response revenue and accelerating growth momentum in the base business.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
The company will provide 2021 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income